SCHEMBL3210941

SCHEMBL3210941

O=S(=O)(c1ccc2ccccc2c1)N1CCN(c2ncccc2Cl)CC1

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 6/20 0.72
SMN1; SMN2 Q16637 2/20 0.57
GAA P10253 1/20 0.57
GBA1 P04062 1/20 0.56
TSHR P16473 2/20 0.56
LMNA P02545 2/20 0.56
USP2 O75604 1/20 0.56
MAPK1 P28482 1/20 0.56
HSD17B10 Q99714 1/20 0.56
MCOLN3 Q8TDD5 2/20 0.56
PKM P14618 2/20 0.55
ABL1 P00519 1/20 0.54
BCR P11274 1/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
KDM4E B2RXH2 1/20 0.53
ALDH1A1 P00352 1/20 0.53
HPGD P15428 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3223586 0.87 HSD11B1 (0.72) HSD11B1SMN1; SMN2GAAGBA1TSHR
SCHEMBL3213169 0.84 HSD11B1 (1.00) HSD11B1
SCHEMBL2963619 0.83 TSHR (0.71) HSD11B1SMN1; SMN2GAATSHRLMNA
SCHEMBL3198863 0.83 HSD11B1 (0.81) HSD11B1GBA1KDM4E
SCHEMBL3210151 0.82 HSD11B1 (0.75) HSD11B1SMN1; SMN2GAAGBA1TSHR
SCHEMBL3221937 0.82 HSD11B1 (0.51) HSD11B1TSHRLMNAUSP2MAPK1
SCHEMBL3217790 0.81 HSD11B1 (1.00) HSD11B1GBA1ABL1BCRMEN1
SCHEMBL3222011 0.81 HSD11B1 (0.76) HSD11B1SMN1; SMN2GBA1TSHRLMNA
SCHEMBL18134604 0.80 MCOLN3 (0.83) SMN1; SMN2TSHRLMNAMCOLN3PKM
SCHEMBL3218052 0.79 HSD11B1 (0.66) HSD11B1GAAGBA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029648-A1 11-Beta HSD1 Inhibitors XIANG JASON SHAOYUN 2010-02-04 US disclosed
US-7632838-B2 11-beta HSD1 inhibitors WYETH (US) 2009-12-15 US disclosed
EP-1981848-A2 11-BETA HSD1 INHIBITORS Wyeth (US) 2008-10-22 EP disclosed
US-20070219198-A1 11-Beta HSD 1 inhibitors WYETH (US) 2007-09-20 US disclosed
WO-2007092435-A2 11-BETA HSD1 INHIBITORS WYETH (US) 2007-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029648-A1 11-Beta HSD1 Inhibitors HSD11B1, HSD3B1, HSD11B2 HSD11B1 1/4885SMN1; SMN2 3575/4885GAA 2353/4885
US-20070219198-A1 11-Beta HSD 1 inhibitors HSD11B1, HSD11B2, HSD3B1 HSD11B1 1/4885SMN1; SMN2 3686/4885GAA 2688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.